Tuesday, February 27, 2007
Company Brief - MBP - Metabolic
Company Brief - MBP - Metabolic
Recent failure (lack of efficacy) at PhII trial sent the share diving to 20c. It was 40c for the past year but spiked at $1.10 early 2007 after news of PhII completion (note though PhII was completed then, the result was not known until now).
Cash about $25m
Shares about 300m
NTA based on cash is about 8.3c per share.
Current price is 2.4 times NTA - still too high.
Watch this stock when price falls below 9c.
Recent failure (lack of efficacy) at PhII trial sent the share diving to 20c. It was 40c for the past year but spiked at $1.10 early 2007 after news of PhII completion (note though PhII was completed then, the result was not known until now).
Cash about $25m
Shares about 300m
NTA based on cash is about 8.3c per share.
Current price is 2.4 times NTA - still too high.
Watch this stock when price falls below 9c.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment